PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspolycystic ovary syndrome
MeSH D011085 - polycystic ovary syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010048:Ovarian cysts
$
Success rate
D011085: 
Polycystic ovary syndrome
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Ferring PharmaceuticalsUrofollitropin Bravelle  2002-05-06   
Clinical Trials
Historical Success Rate
Phase 1
70%
28/40
Phase 2
61%
23/38
Phase 3
75%
27/36
Approved: 1Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Ferring Pharmaceuticals
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use